Literature DB >> 24941215

The airway microbiome of intubated premature infants: characteristics and changes that predict the development of bronchopulmonary dysplasia.

Pablo Lohmann1, Ruth A Luna2, Emily B Hollister2, Sridevi Devaraj2, Toni-Ann Mistretta2, Stephen E Welty1, James Versalovic2.   

Abstract

BACKGROUND: Bronchopulmonary dysplasia (BPD) is associated with perinatal inflammatory triggers. Methods targeting bacterial rRNA may improve detection of microbial colonization in premature infants. We hypothesize that respiratory microbiota differs between preterm infants who develop BPD and those unaffected and correlates with inflammatory mediator concentrations.
METHODS: Twenty-five infants, born at ≤32 wk of gestation and intubated in the first 24 h, were enrolled. Tracheal aspirates were obtained at intubation and on days 3, 7, and 28. Bacterial DNA was extracted, and 16S rRNA genes were amplified and sequenced. Concentrations of interleukins (IL-1β, IL-6, IL-8, IL-10, and IL-12), tumor necrosis factor-α, interferon-γ, lipopolysaccharide (LPS), and lipoteichoic acid (LTA) were measured. Chorioamnionitis was diagnosed by histology. BPD was defined as an oxygen requirement at 36 wk postmenstrual age.
RESULTS: Acinetobacter was the predominant genus in the airways of all infants at birth. Ten infants developed BPD and showed reduced bacterial diversity at birth. No differences were detected in bacterial diversity, cytokines, LPS, and LTA from infants with and without exposure to chorioamnionitis.
CONCLUSION: The airways of premature infants are not sterile at birth. Reduced diversity of the microbiome may be an important factor in the development of BPD and is not associated with differences in inflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24941215     DOI: 10.1038/pr.2014.85

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  53 in total

1.  Human mesenchymal stem cells attenuate hyperoxia-induced lung injury through inhibition of the renin-angiotensin system in newborn rats.

Authors:  Chung-Ming Chen; Hsiu-Chu Chou
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

Review 2.  Lungs, microbes and the developing neonate.

Authors:  Barbara B Warner; Aaron Hamvas
Journal:  Neonatology       Date:  2015-06-05       Impact factor: 4.035

3.  Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia.

Authors:  Charitharth Vivek Lal; Jegen Kandasamy; Kalsang Dolma; Manimaran Ramani; Ranjit Kumar; Landon Wilson; Zubair Aghai; Stephen Barnes; J Edwin Blalock; Amit Gaggar; Vineet Bhandari; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-08-16       Impact factor: 5.464

Review 4.  Intestinal microbiota and its relationship with necrotizing enterocolitis.

Authors:  Ravi Mangal Patel; Patricia W Denning
Journal:  Pediatr Res       Date:  2015-05-20       Impact factor: 3.756

Review 5.  Neonatal mucosal immunology.

Authors:  N Torow; B J Marsland; M W Hornef; E S Gollwitzer
Journal:  Mucosal Immunol       Date:  2016-09-21       Impact factor: 7.313

6.  Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds.

Authors:  Daniel J C Berkhout; Hendrik J Niemarkt; Marc A Benninga; Andries E Budding; Anton H van Kaam; Boris W Kramer; Charlene M Pantophlet; Mirjam M van Weissenbruch; Nanne K H de Boer; Tim G J de Meij
Journal:  Pediatr Res       Date:  2017-11-22       Impact factor: 3.756

7.  Effects of hyperoxia on alveolar and pulmonary vascular development in germ-free mice.

Authors:  Kalsang Dolma; Amelia E Freeman; Gabriel Rezonzew; Gregory A Payne; Xin Xu; Tamas Jilling; J Edwin Blalock; Amit Gaggar; Namasivayam Ambalavanan; Charitharth Vivek Lal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-23       Impact factor: 5.464

8.  Mice without a microbiome are partially protected from lung injury by hyperoxia.

Authors:  Kent A Willis; Joseph F Pierre; Stephania A Cormier; Ajay J Talati
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-30       Impact factor: 5.464

Review 9.  Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment.

Authors:  Jung S Hwang; Virender K Rehan
Journal:  Lung       Date:  2018-01-27       Impact factor: 2.584

Review 10.  Biomarkers, Early Diagnosis, and Clinical Predictors of Bronchopulmonary Dysplasia.

Authors:  Charitharth Vivek Lal; Namasivayam Ambalavanan
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.